Core Viewpoint - Tongda Group (00698.HK) announced the investment of idle funds into various financial products, indicating a strategic move to optimize asset management and enhance returns [1] Group 1 - The company plans to subscribe to several financial products through its indirect non-wholly owned subsidiary, Tongda Chuangzhi [1] - The subscription amounts for the financial products are as follows: RMB 10 million for China Post Financial Products, RMB 10 million for Xinyin Financial Products, and RMB 30 million for China Merchants Bank Financial Products [1]

Core Viewpoint - Tongda Group (00698) announced that its indirect non-wholly owned subsidiary, Tongda Chuangzhi, will utilize idle funds to subscribe to several wealth management products, indicating a strategic move to optimize asset management and generate returns [1] Summary by Category Financial Activities - Tongda Chuangzhi will subscribe to wealth management products from various institutions, including China Post Wealth Management, Xinyin Wealth Management, and China Merchants Bank Wealth Management [1] - The subscription amounts are RMB 10 million for China Post Wealth Management, RMB 10 million for Xinyin Wealth Management, and RMB 30 million for China Merchants Bank Wealth Management, totaling RMB 50 million [1]

Group 1 - The core point of the article is that Tongda Group (00698) announced its indirect non-wholly owned subsidiary, Tongda Chuangzhi, will invest in several financial products using idle funds [1] - The company will subscribe to three financial products, including those from China Post, Xinyin, and China Merchants Bank, with subscription amounts of RMB 10 million, RMB 10 million, and RMB 30 million respectively [1]

Core Viewpoint - Oriental Selection (01797.HK) has announced the subscription of various wealth management products issued by Guangfa Bank and China Merchants Bank, indicating a strategic move to enhance its investment portfolio [1] Group 1: Subscription Details - On September 23, 2025, the company subscribed to a wealth management product from Guangfa Bank with a principal amount of RMB 100 million, offering a non-principal guaranteed expected floating annual return rate of 2.80%, maturing on September 23, 2026 [1] - Prior to the subscription with Guangfa Bank, the company had already subscribed to non-principal guaranteed floating return products with an outstanding principal amount of RMB 700 million that had not yet been redeemed [1] - On September 11, 2025, the company subscribed to a wealth management product from China Merchants Bank with a principal amount of RMB 50 million, offering a non-principal guaranteed expected floating annual return rate ranging from 2.30% to 3.30%, with a minimum term of 14 months from the subscription date [1] - Before the subscription with China Merchants Bank, the company had subscribed to non-principal guaranteed products with a principal amount of RMB 100 million, offering a floating return rate between 2.0% and 3.50% [1]

Core Viewpoint - Rongchang Biologics (09995) has announced an agreement with China Merchants Bank Yantai Branch to invest RMB 350 million of idle funds in a wealth management product [1] Group 1 - The company will utilize its idle self-owned funds for the investment [1] - The investment is scheduled to take place on August 12, 2025 [1]

Core Viewpoint - Rongchang Biologics (09995) has announced an agreement with China Merchants Bank Yantai Branch to invest RMB 350 million of its idle funds in a wealth management product, scheduled for August 12, 2025 [1] Group 1 - The company will utilize RMB 350 million of its idle self-owned funds for the investment [1] - The agreement is part of the company's strategy to manage its idle funds effectively [1]